TNFi Discontinuation During Early Pregnancy Not Linked With Worse RA, JIA Outcomes - Rheumatology Advisor

TNFi Discontinuation During Early Pregnancy Not Linked With Worse RA, JIA Outcomes  Rheumatology Advisor

Discontinuing TNFi therapy before 20 weeks gestation was feasible in wo\men with RA and JIA who enter pregnancy with well-controlled disease.